Hypertension Clinical Trial
Official title:
Effects of Salt and The Amount of Water Consumption Simultaneously On Serum Osmolarity and Their Effects on Hemodynamic Parameters and Inflammation
Diets containing excessive salt (>12 g/day) have negative effects on kidney and
cardiovascular system. Considering this known fact, the investigators aimed to study if the
amount of the water taken with excessive salt had any part on these negative effects by
testing the blood pressure, serum osmolality, endothelial functions, cardiac function,
inflammatory parameters and sympathetic nervous system.
Excessive dietary salt raises the serum osmolality, which triggers the protection mechanisms
of the body. The first mechanism is the secretion of vasopressin from posterior pituitary and
the second one is the polyol mediated aldose reductase enzyme activation in renal tubules. In
the beginning, water and a little amount of salt is reabsorbed from the kidneys for keeping
the serum osmolality in normal ranges by the elevation of vasopressin. Besides the high
levels of vasopressin for long durations may have a role in both developments of hypertension
and the progression/development of chronic kidney disease. Polyol mediated aldose reductase
enzyme turns glucose into sorbitol, which is turned to fructose by sorbitol dehydrogenase
activity. Fructose is degraded by fructokinase activity into toxic substances. With this
pathway, the acute energy need is satisfied, yet uric acid, local oxidative stress, and
inflammatory mediators rise while nitric oxide levels decreasing. These facts are independent
risk factors for both kidney disease progression and hypertension. In addition, excessive
salt intake may elevate the transforming growth factor beta-1 (TGF-B1) levels, which
activates the sympathetic system, inflammation, and endothelial dysfunction.
According to these data, the investigators speculate that if they increase the amount of
water intake while eating the high salt diet they may decrease the toxic effect of salt with
less increase in serum osmolarity. To test this hypothesis, by regulating the salt and water
amount in healthy people's diets, the investigators aimed to evaluate the following these
parameters; biochemical parameters that could affect the blood and urine osmolality, blood
pressure, vascular endothelial functions with the non-invasive flow-mediated dilatation
technique and arterial stiffness, systolic and diastolic functions of the heart by
transthoracic echocardiography. In addition, it was planned to evaluate the hormonal effects
of arginine vasopressin, a long peptide with 39 amino acids, which is longer and easier to
measure than vasopressin levels in serum by measuring the pituitary hormone-derived copeptin.
Although, decreasing the salt intake is the first step of the treatment in hypertension, and
kidney diseases, the compliance rate to less sodium intake is very low (<20%). The
investigators aim is to evaluate the effects of water, which is taken acutely with the
excessive salt intake on cardiovascular system and kidney. The findings of the study will
important for public health. If the investigators prove their hypothesis, they may recommend
increasing high water intake before feeling thirst of which may contribute to decreasing the
prevalence of hypertension and kidney disease.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |